Table 18:
Adverse Effect | MRgFUS (N = 15), n transient (n at 12 mo) | Bilateral DBS (N = 57), n transient (n at 12 mo) | Unilateral DBS (N = 13), n transient (n at 12 mo) |
---|---|---|---|
Procedural Events | |||
Vertigo | 11 (0) | 0 (0) | 0 (0) |
Headache | 9 (0) | 0 (0) | 0 (0) |
Nausea or vomiting | 8 (0) | 0 (0) | 0 (0) |
Warm or flushed feeling | 4 (0) | 0 (0) | 0 (0) |
Stereotactic frame pin-site burn | 2 (0) | 0 (0) | 0 (0) |
Side Effects | |||
Paresthesia (any) | 14 (3) | 2 (1) | 1 (2) |
Gait instability | 5 (0) | 10 (0) | 11 (0) |
Dysarthria | 1 (0) | 10 (6) | 1 (0) |
Weakness | 1 (0) | 4 (1) | 1 (0) |
Dysphagia | 0 (0) | 2 (0) | 0 (0) |
Mental status change | 0 (0) | 3 (3) | 1 (0) |
Complications | |||
DBS hardware infection | NA | 0 (1) | 0 (0) |
DBS lead erosion | NA | 1 (2) | 0 (0) |
Hemorrhage | 0 (0) | 2 (0) | 0 (0) |
Abbreviations: DBS, deep brain stimulation; MRgFUS, magnetic resonance-guided focused ultrasound; N, number of participants in the group; n, number of events reported.
Source: Adapted from Huss et al, 2015.40